Natural Language Processing for Unstructured EHR Data in Preventive Screening
NLP extracts screening gaps from clinical notes that structured data alone cannot find.
Anjali Raghunathan
Editor at Large
Anjali Raghunathan
Anjali Raghunathan covers clinical ai and decision support in preventive care, advanced biomarker panels and longitudinal lab testing and whole-genome sequencing and genetic risk interpretation for The Baseline Panel.
10 stories
Epigenetic Aging Clocks as Longitudinal Health Biomarkers
Tracking biological age changes over time predicts mortality better than single snapshots.
Anjali Raghunathan
Continuous Glucose Monitoring in Metabolically Healthy Adults
Continuous glucose monitors reveal hidden glucose swings in metabolically healthy adults.
Anjali Raghunathan
Longitudinal Biomarker Tracking and Intraindividual Variability
Variability within a person's biomarker readings signals disease before trend lines do.
Anjali Raghunathan
Returning Incidental Findings From Whole-Genome Sequencing
Labs must decide what genetic findings to report and patients need clear consent choices.
Anjali Raghunathan
Hereditary Cancer Risk Genes Beyond BRCA1 and BRCA2
Other inherited cancer genes rival BRCA mutations in clinical importance and screening impact.
Anjali Raghunathan
Polygenic Risk Scores in Primary Care Cardiology
Genetic risk scores work best for patients standard calculators can't confidently categorize.
Anjali Raghunathan
Whole-Genome Sequencing vs Exome Sequencing for Healthy Adults
Exome sequencing offers better odds and lower costs for healthy adults without genetic red flags.
Anjali Raghunathan
Pharmacogenomic Testing in Preventive Medicine Workflows
Health systems are shifting genetic drug testing from reactive fix to preventive habit.
Anjali Raghunathan
What whole-genome sequencing actually changes about preventive care
Whole-genome sequencing shifts prevention from detection to genuine risk identification.
Anjali Raghunathan